Bendamustine Hydrochloride
-
Subject Areas on Research
- Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma.
- Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
- Multicenter, Open-Label, Phase II Study of Bendamustine and Rituximab Followed by 90-Yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe).
- Multiple myeloma, version 1.2013.
- Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
- Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance).